News UK biotech 'unicorn' BenevolentAI raises cash for further ex... R&D firm recently invested in Cambridge R&D base
Digital Healthcare AI market worth $10bn plus by 2024 - report The healthcare artificial intelligence (AI) market is to exceed $10 billion by 2024, according to a new report.
Views & Analysis Why pharma companies need to upgrade their intelligence Pairing AI capabilities with human strengths can bring a competitive edge in this rapidly-changing world.
Views & Analysis Solving the Big Data problem in pharma innovation The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What can be done to overcome this issue?
News Gilead strikes again, penning $5bn deal to buy Tubulis Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
